Platelet TLR4: A critical link in pulmonary arterial hypertension

Circulation Research

Volumn 114, Issue 10, 2014, Pages 1551-1553

  Sun, Zhongjie ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIN RECEPTOR ANTAGONIST; PADGEM PROTEIN; PHOSPHODIESTERASE V INHIBITOR; TOLL LIKE RECEPTOR 4;

BLEEDING TIME; BLOOD; BLOOD FLOW VELOCITY; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; INNATE IMMUNITY; LUNG EMBOLISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; UPREGULATION;

BLOOD PLATELETS; EDITORIALS; INFLAMMATION; PULMONARY ARTERIAL HYPERTENSION; THROMBOSIS; TOLL-LIKE RECEPTOR 4;

ANIMALS; BLOOD PLATELETS; GENE DELETION; HUMANS; HYPERTENSION, PULMONARY; TOLL-LIKE RECEPTOR 4;

EID: 84900871178     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.303945     Document Type: Review

References (18)

1. Crosswhite P, Sun Z. Molecular mechanisms of pulmonary arterial remodeling [published online ahead of print March 25, 2014]. Mol. Med. doi: 10.2119/molmed.2013.00165. http://static.smallworldlabs.com/ molmedcommunity/content/pdfstore/13-165-Crosswhite.pdf. Accessed April 22, 2014
2. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol. 2003;284:C316-C330
3. Balasubramaniam V, Le Cras TD, Ivy DD, Grover TR, Kinsella JP, Abman SH. Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2003;284:L826-L833
4. Jankov RP, Kantores C, Belcastro R, Yi S, Ridsdale RA, Post M, Tanswell AK. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1162-L1170
5. Humbert M, Monti G, Fartoukh M, Magnan A, Brenot F, Rain B, Capron F, Galanaud P, Duroux P, Simonneau G, Emilie D. Platelet-derived growth factor expression in primary pulmonary hypertension: Comparison of HIV seropositive and HIV seronegative patients. Eur Respir J. 1998;11:554-559
6. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest. 2005;115:2811-2821
7. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med. 2005;353:1412-1413
8. Hoeper MM, Barst RJ, Bourge RC, et al. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study. Circulation. 2013;127:1128-1138
9. Launay JM, Hervé P, Peoch K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med. 2002;8:1129-1135
10. Eddahibi S, Guignabert C, Barlier-Mur AM, Dewachter L, Fadel E, Dartevelle P, Humbert M, Simonneau G, Hanoun N, Saurini F, Hamon M, Adnot S. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: Critical role for serotonin-induced smooth muscle hyperplasia. Circulation. 2006;113:1857-1864
11. Uchida S, Schneider A, Wiesnet M, Jungblut B, Zarjitskaya P, Jenniches K, Kreymborg KG, Seeger W, Braun T. An integrated approach for the systematic identification and characterization of heart-enriched genes with unknown functions. BMC Genomics. 2009;10:100
12. Crosswhite P, Sun Z. Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens. 2010;28:201-212
13. Bauer EM, Chanthaphavong RS, Sodhi CP, Hackam DJ, Billiar TR, Bauer PM. Genetic deletion of toll-like receptor 4 on platelets attenuates experimental pulmonary hypertension. Circ Res. 2014;114:1596-1600 .
14. Crosswhite P, Sun Z. Inhibition of phosphodiesterase-1 attenuates coldinduced pulmonary hypertension. Hypertension. 2013;61:585-592
15. Berger G, Azzam ZS, Hoffman R, Yigla M. Coagulation and anticoagulation in pulmonary arterial hypertension. Isr Med Assoc J. 2009;11:376-379
16. Maeda NY, Carvalho JH, Otake AH, Mesquita SM, Bydlowski SP, Lopes AA. Platelet protease-Activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension. Thromb Res. 2010;125:38-43
17. Johnson SR, Granton JT, Mehta S. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest. 2006;130:545-552
18. Anderson JR, Nawarskas JJ. Pharmacotherapeutic management of pulmonary arterial hypertension. Cardiol Rev. 2010;18:148-162